Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3763427018 | Bupivacaine hydrochloride 2.5 mg/mL and epinephrine (as epinephrine bitartrate) 5 microgram/mL solution for injection | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
3763428011 | Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
3763429015 | Product containing precisely bupivacaine hydrochloride 2.5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Is a | Adrenaline and bupivacaine only product in parenteral dose form | true | Inferred relationship | Some | ||
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has BoSS | Adrenaline | true | Inferred relationship | Some | 2 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has BoSS | Bupivacaine hydrochloride | true | Inferred relationship | Some | 1 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has precise active ingredient | Bupivacaine hydrochloride | true | Inferred relationship | Some | 1 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has concentration strength numerator value | 5 | false | Inferred relationship | Some | 2 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has concentration strength numerator value | 2.5 | false | Inferred relationship | Some | 1 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has precise active ingredient | Adrenaline acid tartrate | true | Inferred relationship | Some | 2 | |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Is a | Adrenaline- and bupivacaine-containing product | false | Inferred relationship | Some | ||
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has active ingredient | Bupivacaine | false | Inferred relationship | Some | ||
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has active ingredient | Sympathomimetic agent | false | Inferred relationship | Some | ||
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has active ingredient | Adrenaline | false | Inferred relationship | Some | ||
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Is a | Adrenaline-containing product in parenteral dose form | false | Inferred relationship | Some | ||
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has active ingredient | Bupivacaine hydrochloride | false | Inferred relationship | Some | ||
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Has manufactured dose form | Solution for injection | true | Inferred relationship | Some | ||
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Is a | Bupivacaine-containing product in parenteral dose form | false | Inferred relationship | Some | ||
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set